{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:35:21Z","timestamp":1793954121312,"version":"4.8.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"China National Biotec Group Company Limited"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.07.042","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T17:33:32Z","timestamp":1596216812000},"page":"6274-6279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China"],"prefix":"10.1016","volume":"38","author":[{"given":"Shaohong","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunkai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanwen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10115","key":"10.1016\/j.vaccine.2020.07.042_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(17)32442-X","article-title":"The polio endgame: securing a world free of all polioviruses","volume":"391","author":"Zaffran","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2020.07.042_b0010","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.vaccine.2018.01.019","article-title":"Recipient vaccine-associated paralytic poliomyelitis in China, 2010\u20132015","volume":"36","author":"Wu","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.07.042_b0015","unstructured":"Diop OM, Burns CC, Sutter RW, Wassilak SG, Kew OM, Centers for Disease C, et al. Update on Vaccine-Derived Polioviruses - Worldwide, January 2014-March 2015. MMWR Morb Mortal Wkly Rep 2015;64(23):640\u20136."},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.042_b0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s13312-017-1038-x","article-title":"Vaccine Associated Paralytic Poliomyelitis Unmasking Common Variable Immunodeficiency","volume":"54","author":"Gomber","year":"2017","journal-title":"Indian Pediatr"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.07.042_b0025","doi-asserted-by":"crossref","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","article-title":"Vaccine-derived polioviruses","volume":"210","author":"Burns","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.07.042_b0030","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/infdis\/jiu184","article-title":"Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden","volume":"210","author":"Platt","year":"2014","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.042_b0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.07.042_b0040","article-title":"Chronic hepatitis E in an immunocompetent patient","author":"Wang","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.07.042_b0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12879-018-3422-0","article-title":"The landscape of vaccines in China: history, classification, supply, and price","volume":"18","author":"Zheng","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"41","key":"10.1016\/j.vaccine.2020.07.042_b0050","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2020.07.042_b0055","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.07.042_b0060","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1473-3099(15)00219-4","article-title":"Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study","volume":"15","author":"O'Ryan","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"10011","key":"10.1016\/j.vaccine.2020.07.042_b0065","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(15)00237-8","article-title":"Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial","volume":"386","author":"Sutter","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.042_b0070","first-page":"1","article-title":"Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial","volume":"13","author":"Qiu","year":"2017","journal-title":"Hum Vacc Immunotherap"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.042_b0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jpids\/piv017","article-title":"Immunogenicity of Two Different Sequential Schedules of Inactivated Polio Vaccine Followed by Oral Polio Vaccine Versus Oral Polio Vaccine Alone in Healthy Infants in China","volume":"5","author":"Li","year":"2016","journal-title":"J Pediat Infect Diseases Soc"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.042_b0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/jix577","article-title":"Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan","volume":"217","author":"Saleem","year":"2018","journal-title":"J Infect Diseases"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2020.07.042_b0085","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/cid\/ciy603","volume":"67","author":"Brickley","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.07.042_b0090","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/21645515.2019.1572408","article-title":"Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine","volume":"15","author":"Hotta","year":"2019","journal-title":"Hum Vacc Immunotherap"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20309713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:16Z","timestamp":1759401976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20309713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":18,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20309713"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}